mRNA |
BRD1812 |
CTRPv2 |
pan-cancer |
AAC |
-0.092 |
0.009 |
mRNA |
FK866 |
GDSC1000 |
pan-cancer |
AAC |
-0.08 |
0.01 |
mRNA |
BRD-K30019337 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
0.01 |
mRNA |
AZD6482 |
GDSC1000 |
pan-cancer |
AAC |
0.082 |
0.01 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.091 |
0.01 |
mRNA |
selumetinib:GDC-0941 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.088 |
0.01 |
mRNA |
BRD-K14844214 |
CTRPv2 |
pan-cancer |
AAC |
-0.095 |
0.01 |
mRNA |
ML210 |
CTRPv2 |
pan-cancer |
AAC |
-0.081 |
0.01 |
mRNA |
Nilotinib |
GDSC1000 |
pan-cancer |
AAC |
-0.093 |
0.02 |
mRNA |
isoevodiamine |
CTRPv2 |
pan-cancer |
AAC |
-0.079 |
0.02 |